Health Plans

ACA enrollment misses target

Official numbers are pending, but Reuters notes enrollment appears to be just 3% of the government's goal.

Business briefs: Baxter; Eli Lilly; CDHPs and Statins

Baxter's Alzheimer's treatment is out of the running; Eli Lilly has upped its layoffs; insured consumers are spending less on healthcare; stains and prostate cancer may have an amicable relationship; doctors aren't screening teens for HIV.

Pharmas are from Mars, Payers are from Venus


Pharma needs to step up its sales pitch, looking beyond a drug's top attributes, to convince payers that their drugs are worth the cost.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.